Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC

This is a phase 2, single-arm, open-label clinical trial determining safety and tolerability of AHCC in subjects with HPV-positive patients with Head and Neck Squamous Cell Carcinoma. These are subjects who have undergone surgery or will be undergoing surgery.

Trial Details

NCT ID
NCT06693323
Phase
PHASE2
Sponsor
University of California, Irvine
Status
RECRUITING
Cancer Type
HPV Positive Head and Neck Cancer
Interventions
  • AHCC®capsules
Locations (sample)
  • Orange, California, United States|33.78779,-117.85311

Key Eligibility Criteria

  • Between 18 and 79 years of age.
  • Has a diagnosis of pathologically or cytologically proven HPV positive HNSCC.
  • For patients who have undergone surgery, they must be registered at least 4 weeks after surgery.
  • For patients that have completed surgery, has a high risk disease defined as:

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find HPV Positive Head and Neck Cancer Trials on Trialify →